| 000 | 01790 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512091926.0 | ||
| 264 | 0 | _c19731009 | |
| 008 | 197310s 0 0 eng d | ||
| 022 | _a0007-9014 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoss, A A | |
| 245 | 0 | 0 |
_aIntestinal pseudo-obstruction. _h[electronic resource] |
| 260 |
_bCRC critical reviews in radiological sciences _c1972 |
||
| 300 |
_a363-87 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmyloidosis _xcomplications |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadverse effects |
| 650 | 0 | 4 |
_aCathartics _xadverse effects |
| 650 | 0 | 4 |
_aChagas Disease _xcomplications |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdiagnostic imaging |
| 650 | 0 | 4 |
_aColon _xinnervation |
| 650 | 0 | 4 |
_aColonic Diseases, Functional _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCrohn Disease _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDysautonomia, Familial _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanglionic Blockers _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypokalemia _xcomplications |
| 650 | 0 | 4 |
_aIntestinal Obstruction _xdiagnostic imaging |
| 650 | 0 | 4 |
_aIntestinal Pseudo-Obstruction _xdiagnostic imaging |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 |
_aLead Poisoning _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyotonic Dystrophy _xcomplications |
| 650 | 0 | 4 |
_aMyxedema _xcomplications |
| 650 | 0 | 4 |
_aParasympatholytics _xadverse effects |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xcomplications |
| 650 | 0 | 4 |
_aSympathetic Nervous System _xphysiopathology |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _aGoldberg, H I | |
| 773 | 0 |
_tCRC critical reviews in radiological sciences _gvol. 3 _gno. 3 _gp. 363-87 |
|
| 999 |
_c4152139 _d4152139 |
||